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Abstract 
 
DDX3 is an RNA chaperone of the DEAD-box family that regulates translation. Its yeast ortholog Ded1 controls the 
translation of nearly all mRNAs, whereas DDX3 is thought to regulate only a subset of mRNAs. However, the set of mRNAs 
that are regulated by DDX3 are unknown, along with the relationship between DDX3 binding and activity. Here, we use 
ribosome profiling, RNA-seq, and PAR-CLIP to define the set of mRNAs that are regulated by DDX3 in human cells. We 
find that while DDX3 binds most expressed mRNAs, depletion of DDX3 affects the translation level of only a small subset 
of the transcriptome. We further find that DDX3 binds a site on helix 16 of the human ribosome, placing it immediately 
adjacent to the mRNA entry channel and translation factor eIF4B. Translation changes caused by depleting DDX3 levels or 
through chemical inhibition mimicking a dominant negative allele are different. Taken together, our data defines the subset 
of the transcriptome that is responsive to DDX3 inhibition, with relevance for basic biology and disease states where DDX3 
expression is altered. 
 
Keywords: translational control, DEAD-box proteins, RNA, PAR-CLIP, ribosome profiling, post-transcriptional control 
 
 
 
.CC-BY 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/589218doi: bioRxiv preprint first posted online Mar. 26, 2019; 
Calviello and Venkataramanan et al. 2019 – preprint version 1 – bioRxiv 
 2 
Introduction  
Translation initiation is affected by mRNA structure. The 
DEAD-box RNA chaperone DDX3 and its yeast ortholog 
Ded1p facilitate translation initiation on mRNAs with 
RNA structures in their 5′ untranslated regions (UTRs) 
(Guenther et al. 2018; Lai et al. 2008; Oh et al. 2016; 
Soto-Rifo et al. 2012), a function that is essential in all 
eukaryotes (Sharma and Jankowsky 2014). Dysfunction 
in DDX3 is linked to numerous diseases and cancers, 
including medulloblastoma (Epling et al. 2015; Floor et 
al. 2016b; Jones et al. 2012; Kool et al. 2014; Oh et al. 
2016; Pugh et al. 2012; Robinson et al. 2012; Valentin-
Vega et al. 2016), many other cancer types (Sharma and 
Jankowsky 2014), and de novo developmental delay 
(Deciphering Developmental Disorders 2015; Lennox et 
al. 2018; Snijders Blok et al. 2015; Wang et al. 2018). 
Previous work studied how translation is altered by 
DDX3 variants found in medulloblastoma (Oh et al. 2016; 
Valentin-Vega et al. 2016), which are exclusively 
missense variants that preferentially target conserved 
residues. In contrast, hematological cancers like natural 
killer/T-cell lymphoma (Dufva et al. 2018; Jiang et al. 
2015) and others (Wang et al. 2011; Schmitz et al. 2012) 
also have frequent variants in DDX3X, but they are mostly 
truncating or frameshift variants resulting in decreased 
expression. Changes in gene expression occurring as a 
result of decreased DDX3 levels remain incompletely 
understood.  
Inactivation of Ded1 in yeast leads to polysome 
collapse and global downregulation of translation 
(Chuang et al. 1997; de la Cruz et al. 1997). More recent 
work showed that Ded1 is required for translation of most 
transcripts in yeast using genome-wide approaches 
(Guenther et al. 2018; Sen et al. 2015). In contrast, DDX3 
depletion seems to only affect translation of a subset of 
expressed transcripts (Ku et al. 2018; Lai et al. 2008, 
2010; Lee et al. 2008; Soto-Rifo et al. 2012). Despite the 
importance of DDX3 to normal function and its alteration 
in diverse disease states, the set of genes that depend on 
DDX3 for translation is not clearly defined. Moreover, it 
has been challenging to relate DDX3 binding to 
functional effects on bound mRNAs, and it was unclear if 
DDX3 is functioning outside of translation initiation 
given that binding was detected in coding sequences and 
3′ UTRs (Oh et al. 2016; Valentin-Vega et al. 2016).  
Here, we depleted DDX3 protein levels and measured 
alterations to translation and RNA abundance using 
ribosome profiling and RNA-seq. We also characterized 
DDX3 binding by PAR-CLIP, exploiting the presence of 
T>C mutations as a diagnostic hallmark of protein-RNA 
interactions. We observed robust interactions between 
DDX3 and transcript 5′ UTRs, as well as a specific and 
conserved site on the 40S ribosomal subunit. We found 
that transcripts with structured 5′ UTRs are preferentially 
affected by DDX3. We used an in vitro reporter system to 
conclude that decreases in ribosome occupancy upon 
DDX3 depletion are driven by 5′ UTRs. Taken together, 
our results support a model for DDX3 function where 
interactions with the small ribosomal subunit facilitate 
translation on messages with structured 5′ UTRs, which, 
when inactivated, pathologically deregulates protein 
synthesis. 
 
Methods 
 
NGS data pre-processing 
 
Ribo-seq .fastq files were stripped of the adapter sequences 
using cutadapt. UMI sequences were removed and reads were 
collapsed to .fasta format. Reads shorter than 20 nt were 
removed. Reads were first aligned against rRNA (accession 
U13369.1), and to a collection of snoRNAs, tRNAs and 
miRNA (retrieved using the UCSC table browser) using 
bowtie2 in the ‘local’ alignment mode. 
 
Read Alignment 
 
Reads were mapped to the hg38 version of the genome (without 
scaffolds) using STAR 2.6.0a (Dobin et al. 2013) supplied with 
the GENCODE 25 .gtf file. The following parameter were used:  
 
--alignEndsType EndToEnd (Ribo-seq and PAR-CLIP) 
--outFilterMismatchNmax 2 --outFilterMismatchNoverLmax 
0.04 (Ribo-seq) 
--outFilterMismatchNmax 3 (PAR-CLIP and RNA-seq) 
--outFilterMultimapNmax 20 --outSAMmultNmax 1 --
outMultimapperOrder Random (All) 
 
De-novo splice junction discovery was disabled for all datasets.  
 
PAR-CLIP peak calling 
 
Peak calling for PAR-CLIP reads was performed with 
PARalyzer v1.5 (Corcoran et al. 2011) in the 
“EXTEND_BY_READ” mode using the following parameters: 
BANDWIDTH=3 
CONVERSION=T>C 
MINIMUM_READ_COUNT_PER_GROUP=5 
MINIMUM_READ_COUNT_PER_CLUSTER=5 
MINIMUM_READ_COUNT_FOR_KDE=5 
MINIMUM_CLUSTER_SIZE=8 
MINIMUM_CONVERSION_LOCATIONS_FOR_CLUSTE
R=1 
MINIMUM_CONVERSION_COUNT_FOR_CLUSTER=1 
MINIMUM_READ_COUNT_FOR_CLUSTER_INCLUSIO
N=5 
MINIMUM_READ_LENGTH=13 
MAXIMUM_NUMBER_OF_NON_CONVERSION_MISM
ATCHES=0 
Peaks with more than 10 reads were retained for subsequent 
analysis. 
 
Additionally, wavClusteR (Comoglio et al. 2015) was used to 
call PAR-CLIP peaks using the “mrn” method and automatic 
thresholding calculation. 
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Differential expression analysis 
 
Count matrices for Ribo-seq and RNA-seq were built using 
reads mapping uniquely to CDS regions of protein-coding 
genes, using the Bioconductor packages GenomicFeatures, 
GenomicFiles and GenomicAlignments. DESeq2 (Love et al. 
2014) was used to calculated log2FoldChange values between 
siRNA-treated cells and controls; only genes with BaseMean 
>20 for both RNA and Ribo-seq were retained. Differentially 
expressed genes (“RNA_up” and “RNA_down”) were defined 
using the RNA differential expression, with an adjusted p-value 
cutoff of .01. Riborex (Li et al. 2017) was used to quantify 
translation regulation, using the DESeq2 engine and an adjusted 
p-value cutoff of .05 to define differentially translated genes 
(“TE_up” and “TE_down”). The “RNA_up” class was further 
divided in 2 groups: a mixture of 2 gaussians was fit to a vector 
comprising the difference between the log2FC of RNA and 
Ribo, using the mixtools package; a small difference is 
indicative of concordant RNA and Ribo change, while a 
positive value indicates a change in RNA larger than the change 
in the Ribo-seq (thus resembling the “TE_down” set). The 
means for the two gaussian distributions were set at the values 
of 0 and 0.4;  genes belonging to the second distribution 
(according to the posterior probability of the fit) were removed. 
GO enrichment analysis was performed with the topGO 
package, using the fisher test with default parameters. Gene 
categories with a number of annotated genes between 3 and 
3000 were retained. 
 
Meta-transcript profiles 
 
PARalyzer peaks (and peaks from the POSTAR2 repository 
(Zhu et al.)) were mapped on transcript coordinates using one 
coding transcript per gene: such transcript was chosen to have 
the longest 5′ UTR and the most common annotated start codon 
for that gene. Transcript positions were converted into bins 
using 33 bins for each 5′ UTR, 100 bins for each CDS and 67 
bins for each 3′ UTR. Peak scores (ModeScore for PARalyzer 
peaks) were normalized for each transcript (to sum up to 1), and 
values were summed for each bin to build aggregate profiles. 
When plotting profiles for different RBPs. the aggregate 
profiles were further normalized to a sum of 1. To build the 
average meta-transcript profile in Figure 5 and S4, Conversion 
specificity values were averaged per transcript bin and 
transcript class. 
 
Additional transcript features analysis 
 
To compare read mapping locations within transcripts, a 
window of 25nt around the start codon was subtracted from 
annotated 5′ UTRs and CDS. 5′ UTRs and CDS regions were 
merged for each gene using the “reduce” command from the 
GenomicRanges package. Counts on 5′ UTR and CDS were 
first averaged between replicates. The ratio 5′ UTR to CDS of 
these counts were calculated for each gene, in the siRNA and 
controls condition. The log2 of the ratio siDDX3/control for 
those values represents the skew of counts towards 5′ UTR in 
the siDDX3 condition: 	
5$𝑈𝑇𝑅	𝑟𝑖𝑏𝑜𝑠𝑜𝑚𝑒	𝑠𝑘𝑒𝑤= 𝑙𝑜𝑔4 56𝑅𝑃89:;<𝑅𝑃=>? @AB>>CD 6𝑅𝑃89:;<𝑅𝑃=>? @EFGHIFJK L 
 
 
RNA in silico folding was performed on 5′ UTRs sequences 
using RNAlfold (Lorenz et al. 2016) with default parameters. 
Average ΔG values per nucleotide were calculated averaging 
the ΔG values of each structure overlapping that nucleotide. 
Single-nucleotide values were averaged into bins using the 
same approach used to create meta-transcript profiles above. 
%GC content and T>C transition specificity (defined as 
ConversionEventCount / 
(ConversionEventCount+NonConversionEventCount)) for 
each PAR-CLIP peak were derived using the clusters.csv output 
file from PARalyzer. Peak scores for the wavClusteR peaks 
(using the RelLogOdds column) and crosslinking efficiency 
were extracted from the wavClusteR output. 
Gviz was used to plot tracks for RNA-seq, Ribo-seq and PAR-
CLIP over different genomic regions. Intron size was set to a 
maximum of 150 nt. 
 
Source code for all analysis programs can be found here: 
https://github.com/lcalviell/DDX3_manuscript_analysis.  
 
Ribosome profiling 
 
Flp-In T-REx HEK293 cells transfected with control siPool and 
with DDX3X targeting siPools (siTools Biotech) were washed 
with PBS containing 100 μg/ml cycloheximide, flash frozen on 
liquid nitrogen, lysed in lysis buffer (20 mM TRIS-HCl pH 7.4, 
150mM NaCl, 5 mM MgCl2 1 % (v/v) Triton X-100, 25 U/ml 
TurboDNase (Ambion), harvested, centrifuged at 20,000 g for 
4 min at 4ºC and supernatants were stored at -80ºC. Thawed 
lysates were treated with RNase I (Ambion) at 2.5 U/μl for 45 
min at room temperature with slow agitation. Further RNase 
activity was stopped by addition of SUPERase:In (Ambion). 
Next Illustra MicroSpin Columns S-400 HR (GE Healthcare) 
were used to enrich for ribosome complexes. RNA was 
extracted from column flow throughs with TRIzol (Ambion) 
reagent. Precipitated nucleic acids were further purified and 
concentrated with Zymo-Spin IIC column (Zymo Research). 
Obtained RNA was depleted of rRNAs with Ribo-Zero Gold 
Kit (Human/Mouse/Rat) kit (Illumina), separated in 17% Urea 
gel and stained with SYBR Gold (Invitrogen). Gel slices 
containing nucleic acids 27 to 30 nucleotides long were excised 
and incubated in a thermomixer with 0.3 M NaCl at 4ºC over 
night with constant agitation to elute RNA. After precipitation 
nucleic acids were treated with T4 polynucleotide kinase 
(Thermo Scientific). Purified RNA was ligated to 3′ and 5′ 
adapters, reverse transcribed and PCR amplified. The amplified 
cDNA was sequenced on a HiSeq2000 (Illumina). 
 
PAR-CLIP Experiments 
 
Flp-In T-REx HEK293 cells expressing FLAG/HA-tagged 
DDX3X were labelled with 100 μM 4SU for 16h. After 
labelling PAR-CLIP was performed generally as described 
(Hafner et al. 2010). Briefly, cells were UV-crosslinked and 
stored. Obtained cell pellets were lysed in 3 times the cell pellet 
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volume of NP-40 lysis buffer (50 mM HEPES-KOH at pH 7.4, 
150 mM KCl, 2mM EDTA, 1mM NaF, 0.5% (v/v) NP-40, 0.5 
mM DTT, complete EDTA-free protease inhibitor cocktail 
(Roche)), incubated 10 min on ice and centrifuged at 13,000 
rpm for 15 min at 4ºC. Supernatants were filtered through 5 μm 
syringe filter. Next, lysates were treated with RNase T1 
(Fermentas) at final concentration of 1U/μl for 10 min at room 
temperature. Immunoprecipitation of the DDX3X/RNA 
complexes was performed with Flag magnetic beads (Sigma) 
and was followed by second RNase T1 (Fermentas) digestion 
at final concentration of 10U/μl for 10 min at room temperature. 
After IP beads were incubated with calf intestinal phosphatase 
(NEB) and RNA fragments were radioactively end labelled 
using T4 polynucleotide kinase (Fermentas). Crosslinked 
protein–RNA complexes were resolved on a 4–12% NuPAGE 
gel (Invitrogen) and transferred to a nitrocellulose membrane 
(Whatman). Protein–RNA complex migrating at an expected 
molecular weight was excised. Next RNA was isolated from the 
membrane by proteinase K (Roche) treatment and phenol–
chloroform extraction. Purified RNA was ligated to 3′ and 5′ 
adapter, reverse transcribed and PCR amplified. The amplified 
cDNA was sequenced on a HiSeq2000 (Illumina). 
 
In vitro transcription, capping, and 2′-O methylation of reporter 
RNAs 
 
Annotated 5′ UTRs for selected transcripts were cloned 
upstream of Renilla Luciferase (RLuc) under the control of a 
T7 promoter, with 60 adenosine nucleotides downstream of the 
stop codon to mimic polyadenylation. Untranslated regions 
were cloned using synthetic DNA (Integrated DNA 
Technologies) or by isolation using 5′ RACE (RLM-RACE kit, 
Invitrogen). Template was PCR amplified using Phusion 
polymerase from the plasmids using the following primers, and 
gel purified, as described (Floor and Doudna 2016). 
 
pA60 txn rev: TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT TTT CTG 
CAG 
pA60 txn fwd: CGG CCA GTG AAT TCG AGC TCT AAT 
ACG ACT CAC TAT AGG 
 
100 uL in vitro transcription reactions were set up at room 
temperature with 1-5 micrograms of purified template, 7.5mM 
ACGU ribonucleotides, 30mM Tris-Cl pH 8.1, 125mM MgCl2, 
0.01% Triton X-100, 2mM spermidine, 110mM DTT, T7 
polymerase and 0.2 U/uL units of Superase-In RNase inhibitor 
(Thermo-Fisher Scientific). Transcription reactions were 
incubated in a PCR block at 37 degrees C for 1 hour. 1 uL of 1 
mg/mL pyrophosphatase (Roche) was added to each reaction, 
and the reactions were subsequently incubated in a PCR block 
at 37 degrees C for 3 hours. 1 unit of RQ1 RNase-free DNase 
(Promega) was added to each reaction followed by further 
incubation for 30 minutes. RNA was precipitated by the 
addition of 200 uL 0.3M NaOAc pH 5.3, 15 ug GlycoBlue co-
precipitant (Thermo-Fisher Scientific) and 750 uL 100% EtOH. 
Precipitated RNA was further purified over the RNA Clean & 
Concentrator-25 columns (Zymo Research). Glyoxal gel was 
run to assess the integrity of the RNA before subsequent 
capping and 2′ O-methylation. 
 
20 ug of total RNA was used in a 40 uL capping reaction with 
0.5mM GTP, 0.2mM s-adenosylmethionine (SAM), 20 units of 
Vaccinia capping enzyme (New England Biolabs), 100 units of 
2′-O-Me-transferase (New England Biolabs) and 25 units 
RNasin Plus RNase inhibitor (Promega). The reactions were 
incubated at 37 degrees C for 1 hour, followed by purification 
over the RNA Clean & Concentrator-25 columns (Zymo 
Research) and elution in DEPC H2O. Glyoxal gel was run to 
assess the integrity of the RNA before proceeding to in vitro 
translation reactions.  
 
Transfection of siRNA for in vitro translation 
 
HEK293T cells in 150mM plates were transfected with 20 uL 
of siRNA (against DDX3 or a non-targeting control) using 
Lipofectamine 2000 (Thermo Fisher Scientific), following 
manufacturer’s instructions. Cells were harvested for 
preparation of cellular extracts after 48 hours.  
 
Generation of DDX3 mutant cell lines 
 
DDX3 WT and S228C mutant constructs were synthesized and 
cloned downstream of a CMV promoter (Twist Biosciences). 
40 ug of plasmids were transfected into HEK293T cells using 
Lipofectamine 2000 (Thermo Fisher Scientific), following 
manufacturer’s instructions. Cells were harvested for 
preparation of cellular extracts after 48 hours. 
 
Preparation of cellular extracts for in vitro translation 
 
Three to five 150mm plates of HEK293T cells were trypsinized 
and pelleted at 1000g, 4 degrees C. One cell-pellet volume of 
lysis buffer (10mM HEPES, pH 7.5, 10mM KOAc, 0.5mM 
MgOAc2, 5mM DTT, and 1 tablet miniComplete EDTA free 
protease inhibitor (Roche) per 10 mL) was added to the cell 
pellet and was incubated on ice for 45 minutes. The pellet was 
homogenized by trituration through a 26G needle attached to a 
1 mL syringe 13-15 times. Efficiency of disruption was checked 
by trypan blue staining (>95% disruption target). The lysate 
was cleared by centrifugation at 14000g for 1 minute at 4 
degrees C, 2-5 ul was reserved for western blot analysis, and 
the remainder was aliquoted and flash frozen in liquid nitrogen. 
 
Antibodies 
 
Primary antibodies used in this study include anti-DDX3 
(Bethyl A300-474A; Figure 1), rabbit polyclonal anti-DDX3 
(custom made by Genemed Synthesis using peptide 
ENALGLDQQFAGLDLNSSDNQS; Figure 6; Lee et al. 
2008), anti-actin HRP (Santa Cruz Biotechnology, sc-47778), 
anti-FLAG HRP (Sigma, A8592).   
 
In vitro translation  
 
5 uL in vitro translation reactions were set up with 2.5 uL of 
lysate and 20 ng total RNA (0.84mM ATP, 0.21mM GTP, 
21mM Creatine Phosphate, 0.009units/mL Creatine 
phosphokinase, 10mM HEPES pH 7.5, 2mM DTT, 2mM 
MgOAc, 100mM KOAc, 0.008mM amino acids, 0.25mM 
spermidine, 5 units RNasin Plus RNase inhibitor (Promega) as 
described (Lee et al. 2015). Reaction tubes were incubated at 
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30 degrees C for 45 minutes, and expression of the reporter was 
measured using the Renilla Luciferase Assay System 
(Promega) on a GloMax Explorer plate reader (Promega). Drug 
treatments were performed by incubating the reaction with the 
indicated compound for 15 minutes at 30 degrees C prior to the 
addition of RNA.  
 
Results  
We performed ribosome profiling to determine the set of 
transcripts that are regulated by DDX3. DDX3X is an 
essential gene (Chen et al. 2016; Lee et al. 2008), so we 
transiently knocked down its expression using siRNA and 
collected ribosome protected footprints (Figure 1A,B). 
Measuring changes in both RNA abundance and 
ribosome occupancy enabled us to distinguish between 
different modes of DDX3-mediated regulation. High 
correlations between replicate experiments indicate 
reproducibility of the results (Figure S1A). Many genes 
with increased RNA expression also showed mild 
reduction in their translation level, small enough to not 
meet our threshold criteria. We used a Gaussian mixture 
model to deconvolve these groups (Methods; Figure 
S1B). Unlike its yeast ortholog Ded1p, we find that 
depletion of DDX3 only affects ribosome occupancy of 
two percent of messages (Figure 1C). Almost 90% of 
ribosome occupancy changes upon DDX3 depletion are 
decreases, consistent with a role of DDX3 in promoting 
translation of select mRNAs (Figure 1C,D). We note that 
transcripts whose RNA level changes after DDX3 
depletion tend to have high basal expression level and 
small fold changes (Figure S1C). Interestingly, histone 
mRNAs modestly increase in translation upon DDX3 
depletion (Figure 1D). Surveying the list of genes affected 
by DDX3 depletion revealed canonical genes that are 
subject to translational control, such as the oncogene 
ODC1 (Figure 1E, Table S1). Diverse biological 
pathways are affected by DDX3 depletion, revealing the 
enrichments of histone in translationally upregulated 
mRNAs (“TE_up”), and genes related to neuronal 
branching in the translationally downregulated set 
(“TE_down”) (Figure S1C). 
DDX3 is thought to regulate translation through 
transcript 5′ UTRs, and we found genes that are regulated 
by their 5′ UTRs such as ODC1 in the translationally 
downregulated set (Figure 1E; Auvinen et al. 1992; Steeg 
et al. 1991). We therefore measured the enrichment of 
ribosomes in transcript 5′ UTRs, under the hypothesis that 
depletion of DDX3 might lead to defective scanning and 
ribosome accumulation (Guenther et al. 2018), or 
selective ribosome depletion on coding sequences. 
Indeed, we find more ribosomes in transcript 5′ UTRs 
relative to coding sequences upon DDX3 depletion 
(Figure 2A), especially in mRNAs that show translational 
downregulation. An example gene with increased 5′ UTR 
ribosome occupancy is shown in Figures 2B and S2A 
(HMBS), which is regulated by upstream ORF (uORF) 
translation. We considered features within the 5′ UTR that 
could potentially contribute to a transcript’s sensitivity to 
reduced DDX3 levels, and observed that the length of 5′ 
UTRs that are sensitive or insensitive to DDX3 depletion 
are similar (Figure 2C). However, DDX3-dependent 5′ 
UTRs have higher GC content (Figure 2C), consistent 
with the relationship between 5′ UTR structure and 
ribosome scanning (Kozak 1986).  Other regions of these 
DDX3-dependent mRNAs also show a high-GC signature 
(Figure S2B). We examined predicted RNA secondary 
structure in 5′ UTRs and found that mRNAs that decrease 
in translation upon DDX3 depletion have regions with 
lower predicted RNA folding free energy than transcripts 
that are not dependent on DDX3 (Figure 2D). The 
position of a structure in RNA is thought to influence the 
requirement for DDX3 (Soto-Rifo et al. 2012), so we 
examined predicted structure across 5′ UTRs. 
Interestingly, DDX3-sensitive transcripts have higher 
predicted structure through the entire 5′ UTR and not just 
at the 5′ end (Figure S2C).  
To better define the set of DDX3-sensitive 
transcripts, we measured DDX3 binding sites with high 
specificity using PAR-CLIP. Previous work using a 
complementary method (iCLIP) to measure DDX3 
binding sites identified 5′ UTR and ribosomal RNA 
binding. Curiously, even though DDX3 is thought to 
regulate translation initiation, binding was also identified 
in coding sequences and 3′ UTRs (Oh et al. 2016; 
Valentin-Vega et al. 2016). Here, we leveraged the 
additional specificity afforded by T>C transitions induced 
by protein adducts on crosslinked uridine residues in 
PAR-CLIP to reexamine these findings. We treated cells 
with 4-thiouridine (4sU) and used UV-A crosslinking at 
365 nanometers to crosslink RNA and protein complexes 
(Hafner et al. 2010).  
High-throughput sequencing of RNA fragments 
crosslinked to DDX3 identified a binding site for DDX3 
on the 18S ribosomal RNA (Figure 3; Eliseev et al., 2018) 
with high replicability (Figure S3A). Interestingly, while 
there were many rRNA fragments sequenced following 
PAR-CLIP (Figure S3A), there were only two sites with 
high-confidence T>C transitions (Figure 3B). The major 
interaction site maps to helix 16 of the 18S rRNA, similar 
to where Ded1p crosslinks to rRNA in yeast (Guenther et 
al. 2018). Helix 16 is on the small ribosomal subunit 
facing incoming mRNA, which might provide DDX3 
access to resolve mRNA secondary structures to facilitate 
inspection by the scanning 43S complex (Figure 3C). 
Interestingly, the crosslink site on h16 is just opposite the 
eIF4B binding site, another factor crucial in ribosome 
recruitment and scanning (Sen et al. 2016; Walker et al. 
2013). This is consistent with observations that eIF4B and 
Ded1 cooperate in translation initiation on mRNAs (Sen 
et al. 2016), and consistent with a previously reported 
interaction between DDX3 and eIF3 (Lee et al. 2008).  
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In addition to ribosomal RNA binding, we found that 
DDX3 binds primarily to coding transcripts (Figure 4A). 
We find high confidence peaks for DDX3 binding in 67 
percent of expressed mRNAs (Figure 4B, S4A, Table S2), 
considerably more than are translationally regulated 
(Figure 1C). To identify where DDX3 binds mRNAs, we 
averaged reads across all expressed transcripts in a 
metagene analysis. We found that DDX3 primarily binds 
to transcript 5′ UTRs, with a small number of reads 
mapping in the coding sequence and 3′ UTR (Figure 4C). 
We used available CLIP data to compare the binding 
pattern of DDX3 to other known mRNA binders (Zhu et 
al. 2019). We selected three RNA-binding proteins to 
compare to: eIF3b is a member of the multi-subunit 
initiation factor eIF3 (Aitken et al. 2016), FMR1 interacts 
with elongating ribosomes (Chen et al. 2014), and 
MOV10 is involved in 3′ UTR-mediated mRNA decay 
(Gregersen et al. 2014; Sievers et al. 2012). The binding 
pattern of DDX3 most closely resembles the initiation 
factor eIF3b (Figure 4C). However, we detected some 
DDX3 binding within coding sequences and even 3′ 
UTRs. We used the frequency of T>C transitions at each 
site as a measure of the specificity of protein-RNA 
interaction (Figure S4B; Mukherjee et al. 2018). 
Interestingly, high specificity crosslinks with frequent 
T>C transitions reside most often in 5′ UTRs, especially 
near the start codon (Figure S4C). We also find DDX3 
binding to transcript 5′ UTRs whose translation decreases 
upon DDX3 depletion, such as PRKRA and ODC1 
(Figure 4D and S4D). Confirmation of this binding 
pattern comes from an independent assay of protein-RNA 
interaction, as measured by eCLIP (Figure S4E; Van 
Nostrand et al. 2016). Taken together, we conclude that 
DDX3 primarily functions as a translation initiation 
regulator by binding to transcript 5′ UTRs. 
Since we found that DDX3 binds to transcript 5′ 
UTRs of messages that decrease in translation upon 
DDX3 depletion such as PRKRA (Figure 4D), we sought 
to determine if there was a relationship between DDX3 
binding and translation changes. DDX3 binds a large 
majority of cellular transcripts (Figure S4A) but only 
regulates a small fraction of them (Figure 1), suggesting 
there are differences between the transcripts that are 
translationally controlled by DDX3 versus those that are 
not. We hypothesized that there is a relationship between 
the structure of a transcript’s 5′ UTR and its dependence 
on DDX3, as has been observed in the yeast ortholog 
Ded1p (Guenther et al. 2018; Gupta et al. 2018) and for 
individual mRNAs (Ku et al. 2018; Lai et al. 2008, 2010; 
Soto‐Rifo et al. 2012). We find that there is increased T>C 
conversion specificity in the 5′ UTR of transcripts whose 
translation decreases upon DDX3 depletion (Figure 5A). 
An example of coordinate binding and regulation by 
DDX3 is the ODC1 gene (Figure S4D). We analyzed the 
average GC content in PAR-CLIP peaks across mRNAs 
stratified by the nature of translation changes upon DDX3 
depletion, and find that the set of translationally 
downregulated genes have elevated GC content in peaks 
in their 5′ UTRs (Figure 5B). Despite a clear reported 
preference of DDX3 binding to structured RNAs, we 
reasoned that such a sequence enrichment might also 
result from inherent biases of PAR-CLIP in determining 
binding specificity. We observed a consistent, albeit 
weak, correlation between peak scores and %GC content 
for published PAR-CLIP peaks (Figure S5A) for 50  
RNA-binding proteins (Zhu et al. 2018), confirming the 
presence of possible biases inherent to the experimental 
protocol and/or analysis (Friedersdorf and Keene 2014). 
However, a similar binding pattern, enriched in 5′ UTRs 
of downregulated transcripts, was confirmed using a 
different PAR-CLIP peak calling strategy (Figure 
S5B,C). Taken together, we conclude that while T>C 
conversion specificity is potentially confounded by GC 
content, the set of mRNAs that DDX3 regulates 
nevertheless have increased binding relative to all 
expressed transcripts.  
Our data suggest that DDX3 directly affects 
translation of a subset of mRNAs. However, ribosome 
profiling measures ribosome occupancy and does not 
distinguish between elongating or stalled ribosomes. 
Given that DDX3 binds primarily to 5′ UTRs, and that 
DDX3 binding is enriched in transcripts it regulates 
(Figure 5, S5), we reasoned the ribosome occupancy 
changes observed here are likely due to altered translation 
initiation at the main start codon. To test this, we cloned 
DDX3-sensitive 5′ UTRs from this work and previous 
work (Oh et al. 2016) upstream of a Renilla luciferase 
reporter, which is not sensitive to DDX3 depletion 
(Figure 6A, Table S3). As the annotated DVL2 5′ UTRs 
are nested, we cloned the prevalent isoforms in HEK 
293T cells using 5′ RACE. We then made translation 
extracts from HEK 293T cells transfected with a 
nontargeting control siRNA or a DDX3 siRNA (Figure 
6B). Next, we in vitro transcribed, capped, and 2′-O 
methylated the reporter RNAs and performed in vitro 
translation in wild-type or DDX3-depleted lysate. We 
find that 5′ UTRs from DDX3-sensitive mRNAs (Figure 
1D, 4D) also confer DDX3 dependence to the luciferase 
reporter  (Figure 6C; PRKRA, DVL2); translation of the 
Rluc control, containing a generic 5′ UTR sequence, was 
not affected. Therefore, based on these reporter 
experiments and DDX3 binding pattern, we interpret 
ribosome occupancy changes upon DDX3 depletion as a 
result of mis-regulated translation initiation dynamics.  
However, translation of RPLP1 was unchanged upon 
DDX3 depletion (Figure 6C). RPLP1 was identified as an 
mRNA with uORF occupancy changes upon mutant 
DDX3 expression in prior work (Oh et al. 2016). This 
suggests there may be different effects on translation 
between depletion of DDX3 and expression of a dominant 
negative mutant. Interestingly, patients carrying 
inactivating point mutations in DDX3 display more 
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severe clinical symptoms than patients with truncating 
mutations (Lennox et al. 2018). Point mutations in DDX3 
associated with medulloblastoma are dominant negative 
and act by preventing enzyme closure of DDX3 towards 
the high-RNA-affinity ATP-bound state (Epling et al. 
2015; Floor et al. 2016b; Jones et al. 2012; Kool et al. 
2014; Pugh et al. 2012; Robinson et al. 2012). We 
therefore tested chemical inhibition of DDX3, which 
functionally mimics a dominant negative mutation by 
blocking ATP binding. We were unable to inhibit 
translation in a DDX3-dependent manner using RK-33 
(Bol et al. 2015), and instead found that it acted as a 
general translation inhibitor (Figure S6). We therefore 
used a recently established chemical genetic approach for 
inhibiting DEAD-box proteins by introducing a cysteine 
near the active site (Barkovich et al. 2018; Floor et al. 
2016a). We made translation extracts with wild-type 
DDX3 or DDX3 S228C, which is sensitive to the 
electrophilic inhibitor AMP-acrylate (Figure 6D,E). 
Interestingly, we find that chemical inhibition of DDX3 
decreases translation of all tested reporters but not the 
generic 5′ UTR sequence in the Rluc control (Figure 6E). 
Taken together, we find that DDX3 sensitivity for 
translation is preserved in translation extracts and that 
depletion of DDX3 appears to have different outcomes on 
translation than inhibition or dominant negative variants.  
 
Discussion  
DDX3X is an essential human gene that is altered in 
numerous disease states. Here, we use a set of 
transcriptomics approaches and biochemistry to show that 
DDX3 regulates a subset of the human transcriptome, 
likely through resolving RNA structures. We further show 
that inactivating point mutations in DDX3 yield different 
outcomes than depletion. Reporter experiments that show 
these 5′ UTRs are sufficient to confer DDX3 sensitivity 
onto unrelated coding sequences. We conclude that 
DDX3 affects translation initiation through interacting 
with transcript 5′ UTRs. Our data firmly establish that the 
major role of DDX3 is in translation initiation, and reveal 
translation differences between mutated and 
haploinsufficient DDX3 expression.  
We identified binding between DDX3 and helix 16 
(h16) on the human 40S ribosome. This is similar to 
binding sites identified previously (Guenther et al. 2018; 
Oh et al. 2016; Valentin-Vega et al. 2016), but 
strengthened here using T>C transitions defined by PAR-
CLIP. Interestingly, histone mRNAs increased translation 
upon DDX3 knockdown (Figure 1D), and their translation 
is dependent on mRNA binding to the rRNA h16 helix 
(Martin et al. 2016). Our data suggests the possibility that 
there is competition for h16 between DDX3 and histone 
mRNAs, and their translation increases upon DDX3 
knockdown due to increased accessibility to h16. 
However, histone mRNAs contain highly repetitive 
sequences and lack a poly-A tail, perhaps requiring a 
more tailored approach to precisely investigate the 
mechanisms of their regulation. The set of mRNAs that 
require h16 for their translation will be an interesting 
direction to pursue in the future.  
Despite primarily affecting translation, some genes 
exhibited mild changes in steady-state RNA abundance 
upon DDX3 depletion. RNA-level changes could be 
mediated by indirect effects of a DDX3-dependent 
translation target or reflect additional mechanisms by 
which DDX3 regulates gene expression. For instance, the 
up-regulation of mRNAs encoding secretory proteins 
(CHGA, CHGB, SCG3) or of highly abundant RNAs 
(Figure 1D, S1C) might hint to possible roles of DDX3 in 
ER-mediated RNA processes or as a more general 
regulator of cytoplasmic RNP complexes. For instance, 
DDX3 is an important factor in stress-granule complexes 
(Shih et al. 2012). Alternatively, RNA-level changes 
could reflect differences in co-translational RNA decay 
pathways. Potential interactions between DDX3 
regulation of both ribosome occupancy and RNA levels 
will be further explored in future studies.  
DDX3 is an abundant protein, with approximately 1.4 
million copies per HeLa cell (Kulak et al. 2014), or about 
half the abundance of ribosomes (Duncan and Hershey 
1983). We have interpreted data in this work by 
hypothesizing that DDX3 is functioning in cis by binding 
to the 40S ribosome and facilitating translation initiation 
on the associated mRNA. It is also possible that DDX3, 
alone or in combination with other abundant DEAD-box 
proteins like eIF4A, functions in trans by activating an 
mRNA prior to 43S complex loading and then binds to 
the 43S complex. Future work defining the binding site of 
DDX3 on the ribosome could enable separation of cis and 
trans functions to test these two models, although we note 
that the functional consequences of DDX3 depletion we 
have observed here are independent of its functioning in 
cis or trans. 
We find 249 mRNAs change in translation level upon 
DDX3 depletion following joint replicate analysis (Figure 
1C), although DDX3 binds to over 9,000 mRNAs (Figure 
4B, S4A). Therefore, not all mRNAs bound by DDX3 are 
strongly affected upon DDX3 depletion. This is markedly 
different than the observed requirement for Ded1 in 
translation of most yeast mRNAs (Guenther et al. 2018; 
Sen et al. 2015; Chuang et al. 1997; de la Cruz et al. 1997). 
mRNAs that require DDX3 for translation have a 
molecular signature involving increased 5′ UTR 
secondary structure (Figure 5). Genes that produce 
mRNAs that depend on DDX3 for translation include 
potent regulators of cellular state, such as disheveled 1 
and 2 (DVL1 and DVL2), many transcription factors (e.g. 
E2F1, E2F4, TCF3, HES6, and ELK1), and transforming 
growth factor beta 1 (TGFB1; Table S1). However, the 
set of regulated mRNAs will change between cell types 
and states depending on the set of expressed transcripts 
that contain this molecular signature. Thus, it becomes 
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challenging to establish directness for phenotypic changes 
that result from DDX3 knockdown, since DDX3 could be 
directly mediating the phenotype or indirectly mediating 
the phenotype through translational deregulation of a 
phenotypic effector.  
DDX3 is altered in numerous human diseases, 
including cancers and developmental disorders (Sharma 
and Jankowsky 2014). Some diseases are characterized by 
missense variants (Jones et al. 2012; Kool et al. 2014; 
Pugh et al. 2012; Robinson et al. 2012), while others 
involve predominantly nonsense or frameshift variants 
(Dufva et al. 2018; Jiang et al. 2015), and still others 
present with a mixture of variant types (Deciphering 
Developmental Disorders 2015; Lennox et al. 2018; 
Wang et al. 2018). Our work here suggests that 
haploinsufficient variants in DDX3 that deplete protein 
levels may result in different translation changes than 
missense variants that yield dominant negative proteins. 
We attempted to directly compare translational changes 
upon DDX3 depletion identified in this work with 
previous expression of mutant DDX3 but stopped due to 
confounding variability in biological sample and library 
preparation and sequencing protocols. An intriguing 
direction for the future is to determine in an isogenic 
background how different mutation types in DDX3 affect 
gene expression, the underlying molecular mechanisms, 
and potential therapeutic interventions.  
 
Data access 
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Figure 1: Translational changes upon DDX3 depletion. (A) A workflow of the experimental system. 
(B) siRNA knockdown efficiency of DDX3 analyzed by western blot. (C) Information on the number of 
genes that change translation upon DDX3 depletion. TE: translation efficiency. Parentheses: RNA_
up genes after mixture model filtering (see Methods). (D) Differential expression analysis of RNA 
and ribosome profiling changes upon DDX3 depletion. RP: ribosome profiling. Point size indicates 
differential translation  (as defined by Riborex). (E) Diminished translation of ODC1 mRNAs following 
DDX3 depletion (compare RP_siDDX3 to RP_ctrl). 
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Figure 2: DDX3-sensitive transcripts have complex 5′ leaders. (A) The fold-change of the ratio in 
ribosome occupancy in the 5′ UTR versus the coding sequence upon DDX3 depletion (Methods). (B) 
An example gene (HMBS) with increases in 5′ UTR ribosomes versus coding sequence ribosomes. 
(C) DDX3-sensitive mRNAs (TE_down) have similar length 5′ UTRs but higher GC content. (D) 
DDX3-sensitive mRNAs (TE_down) have more predicted 5′ UTR structure than other mRNAs.
A
C
B
D
TE_down
TE_up
RNA_down
RNA_up
Not_significant
−4 −2 0 2 4
log2FC_5'UTR_skew
Tx
_c
la
ss
More ribosomes in 
5′ UTR in siDDX3
5′ UTR ribosome skew (siDDX3 vs control)
Less ribosomes in 
5′ UTR in siDDX3
TE_down
TE_up
RNA_down
RNA_up
Not_significant
0 10 100 1000 10000
5'UTR length
tx
_t
yp
e
TE_down
TE_up
RNA_down
RNA_up
Not_significant
0 25 50 75 100
%GC content in 5'UTR
tx
_t
yp
e -40
-35
-30
-25
-20
-15
TSS 20 40 60 80 start codon
5'UTR position (bins)
av
er
ag
e 
Δ
G Transcript class
Not_significant
RNA_down
RNA_up
TE_down
TE_up
HMBS5′ UTR
5′ UTR lengt
5′ UTR GC content
Tr
an
sc
rip
t c
la
ss
Tr
an
sc
rip
t c
la
ss
5′ UTR po ition (binned)
A
ve
ra
ge
 Δ
G
R
P
si
D
D
X
3
R
N
A
si
D
D
X
3
R
P
co
nt
ro
l
R
N
A
co
nt
ro
l
Calviello, Venkataramanan et al. Figure 2
.CC-BY 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/589218doi: bioRxiv preprint first posted online Mar. 26, 2019; 
eIF3
eIF3b
WD40
DDX3 
PAR-CLIP
eIF4B
18S rRNA
Ribosomal
proteins
mRNA 5′
mRNA 3′
eIF2
Figure 3: DDX3 binding sites on rRNA identified by PAR-CLIP. (A) a workflow of the PAR-CLIP 
experiment. (B) PAR-CLIP peaks on human rDNA (top) compared to iCLIP from previous work 
(bottom). (C) The PAR-CLIP peak on the 18S rRNA is visualized in red on the structure of the 48S 
ribosome (PDB 6FEC), with a zoom on the right. A portion of the mRNA was observed in the structure 
shown in cyane surface with additional mRNA modeled as a dashed line.
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Figure 4: DDX3 binds to mRNA 5’ leaders, similar to canonical initiation factors. (A) Most of 
the non-rRNA bound by DDX3 is coding RNA. (B) DDX3 binds to many coding mRNAs, many more 
than it translationally regulates. However, high confidence T>C transitions are moderately enriched in 
the genes that are sensitive to DDX3 knockdown. (C) A metagene plot of DDX3 and other PAR-CLIP 
data. eIF3B is a canonical initiation factor, FMR1 binds elongating ribosomes, and MOV10 is a 3′ 
UTR binding factor. (D) An example of a gene that is bound and translationally controlled by DDX3. 
Note there is another transcript of PRKRA with an extended 5′ UTR that spans the first intron above.
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Figure 5: DDX3 binding regulates translation of GC-rich transcripts. 
(A, B) Metagene tracks of T>C conversion specificity (A) and GC content within PAR-CLIP peaks (B) 
for different gene classes across transcript bins. 
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Figure 6: Chemical inhibition of DDX3 affects translation differently than knockdown. 
(A) Diagrams of the reporter constructs used to test DDX3-dependent translation. (B) Knockdown of 
DDX3 using siRNA to make translation lysates. (C) Translation of in vitro transcribed reporter RNAs 
in siNTC (non targeting control) or siDDX3 HEK 293T lysates. (D) Expression of either WT DDX3 or 
DDX3 S228C, which is sensitive to electrophile inhibitors. (E) Addition of AMP-acrylate decreases 
translation of a different set of DDX3-sensitive mRNAs than knockdown.
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Figure S1: Related to Figure 1 ribosome profiling.
(A) Replicate correlations for RNAseq and ribosome profiling libraries. Red dots: the DDX3X gene. 
(B) Correction of RNA_up genes by mixture modeling (methods). (C) Gene ontology terms enriched 
in various gene sets.
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Figure S2: Related to Figure 2 ribosome profiling feature analysis
(A) RNA-seq and Ribo-seq tracks for individual replicates across the HMBS gene. (B) mRNA features 
associated with indicated gene sets. (C) Predicted RNA structure for the first, middle, and last 100 
nucleotides of 5′ untranslated regions in indicated gene sets. 
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Figure S3: Related to PAR-CLIP.
(A) rDNA tracks for replicate experiments of PAR-CLIP (this work) and iCLIP from Oh et al 2016.
A
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Figure S4: Related to Figure 4 PAR-CLIP - mRNA analysis
(A) Scatter plot of PAR-CLIP TPMs and Ribo-seq TPMs showing that DDX3 binding is proportional to 
ribosome occupancy for most genes. (B) A histogram of T>C conversion specificity for each PARalyz-
er PAR-CLIP peak. (C) Aggregate PAR-CLIP peak scores from PARalyzer stratified by T>C conver-
sion specificity thirtiles across transcript regions. (D) Ribo-seq, RNA-seq and PAR-CLIP reads across 
the ODC1 gene. (E) Plotting aggregate RBP binding data from eCLIP shows that the DDX3 mRNA 
binding pattern is similar in an unrelated cell type (K562) and using a complementary approach 
(eCLIP). 
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Figure S5: Related to Figure 5 
(A) Pearson (top) and spearman (bottom) correlations between peak scores and GC content across 
50 published PAR-CLIP datasets with scores from the POSTAR2 database. (B) Aggregate PAR-CLIP 
peak scores from wavClusteR stratified by crosslinking efficiency thirtiles across transcript regions. 
(C) Average peak scores from PAR-CLIP called by wavClusteR for indicated transcript groups across 
transcript regions. 
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Figure S6: Related to Figure 6 in vitro translation 
(A) In vitro translation with the small molecule RK-33 reveals DDX3-independent inhibition of mRNA 
translation (compare Rluc control to DDX3-specific 5’ UTR reporters).
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